How to Get Lumizyme (Alglucosidase Alfa) Covered by Aetna CVS Health in Ohio: Complete Authorization Guide
Answer Box: Getting Lumizyme Covered by Aetna CVS Health in Ohio
Aetna requires prior authorization for Lumizyme (alglucosidase alfa) with confirmed Pompe disease diagnosis and specialist prescription. The fastest path to approval involves three key steps: (1) Submit the Aetna Lumizyme Precertification Form with enzyme/genetic testing results from your metabolic specialist, (2) Enroll with CVS Specialty Pharmacy at 1-800-237-2767 after approval, and (3) If denied, use Ohio's two-level internal appeals process followed by external review through the Ohio Department of Insurance within 180 days.
Table of Contents
- Is Lumizyme Covered by Aetna CVS Health?
- Prior Authorization Requirements
- How Long Does Approval Take?
- Medical Necessity Criteria
- Understanding Your Costs
- Common Denials and Appeals in Ohio
- When to Renew Authorization
- CVS Specialty Pharmacy Enrollment
- Troubleshooting Common Issues
- Frequently Asked Questions
Is Lumizyme Covered by Aetna CVS Health?
Yes, Lumizyme is covered by Aetna CVS Health plans, but requires prior authorization and has moved to non-preferred status in 2025. This means higher out-of-pocket costs compared to preferred alternatives like Nexviazyme.
Which Plans Cover Lumizyme?
Aetna covers Lumizyme across commercial plans, with CVS Caremark managing pharmacy benefits and CVS Specialty handling dispensing. Coverage applies to:
- Individual and family plans
- Employer-sponsored group plans
- Medicare Advantage plans (with Part B coverage for IV infusions)
Note: Self-funded employer plans follow ERISA rules rather than Ohio state insurance laws, but many voluntarily use similar appeal processes.
Prior Authorization Requirements
Who Submits the Authorization?
Your prescribing physician (typically a metabolic or lysosomal storage disorder specialist) must submit the prior authorization request using the Aetna Lumizyme Precertification Form.
Required Documentation
Clinical Evidence:
- Confirmed Pompe disease diagnosis via enzyme assay showing GAA deficiency OR genetic testing
- Prescription from metabolic/lysosomal storage disorder specialist
- Standard dosing: 20 mg/kg every 2 weeks via IV infusion
- Site of care justification (hospital outpatient, infusion center, or home)
Patient Information:
- Demographics and insurance details
- Previous treatment history and outcomes
- Any adverse reactions to alternative therapies
How to Check Authorization Status
Contact Aetna Precertification at 1-866-752-7021 or check through the Aetna provider portal (verify current link with your clinic).
How Long Does Approval Take?
Standard Timeline
- Prior authorization decision: 14 days from complete submission
- CVS Specialty enrollment: 2 business days after approval
- Drug availability: 3-5 business days after enrollment
Expedited Review
If delaying treatment would seriously harm your health, request expedited review:
- Decision timeline: 72 hours with physician urgency certification
- Documentation required: Specialist letter explaining medical urgency
Tip: Submit within 3-5 business days of your specialist consultation for fastest processing.
Medical Necessity Criteria
Initial Approval Requirements
Diagnostic Confirmation:
- Enzyme assay showing acid alpha-glucosidase (GAA) deficiency
- OR genetic testing consistent with Pompe disease
- Specialist evaluation and prescription
Step Therapy Considerations: Aetna now requires trying Nexviazyme first for late-onset Pompe disease unless you have:
- Documented contraindication to Nexviazyme
- Previous intolerance or ineffective response
- Current stability on Lumizyme therapy
Continuation Criteria
Coverage continues for 12 months when you demonstrate clinical response through:
- Improvement or stabilization in motor function
- Maintained or improved walking capacity
- Stable cardiorespiratory function
- Decreased left ventricular mass index (LVMI)
- Delayed mortality risk
Understanding Your Costs
Formulary Status Impact
With Lumizyme's move to non-preferred status, expect higher out-of-pocket costs. Exact copay amounts vary by plan, but non-preferred specialty drugs typically have higher coinsurance rates.
Cost-Saving Options
Manufacturer Support:
- Sanofi patient assistance programs (verify eligibility at manufacturer website)
- Copay assistance cards for eligible commercial insurance patients
Foundation Grants:
- National Organization for Rare Disorders (NORD) patient assistance
- HealthWell Foundation grants for rare disease treatments
Common Denials and Appeals in Ohio
Why Aetna Denies Lumizyme
| Denial Reason | How to Overturn |
|---|---|
| Not medically necessary | Provide 6-minute walk test decline, FVC results, specialist progression notes |
| Step therapy not met | Document Nexviazyme trial failure, adverse events, or contraindications |
| Non-formulary status | Request formulary exception with medical necessity documentation |
| Dosing concerns | Include weight-based calculations, specialist dosing rationale |
Ohio Appeals Process
Level 1 Internal Appeal:
- Deadline: 180 days from denial
- Decision timeline: 30 days (standard), 72 hours (expedited)
- Submission: Aetna member portal or written request
Level 2 Internal Appeal:
- Deadline: 60 days from Level 1 denial
- Decision timeline: 30 days (standard), 72 hours (expedited)
- Requirements: Include new clinical evidence not previously submitted
External Review (Ohio):
- Deadline: 180 days from final internal denial
- Decision timeline: 30 days (standard), 72 hours (expedited)
- Authority: Independent Review Organization (IRO) decision is binding on Aetna
- Process: Submit request to Aetna, which notifies Ohio Department of Insurance
Ohio Advantage: Even if Aetna claims your case isn't eligible for external review, the Ohio Department of Insurance can independently determine eligibility and order a review.
When to Escalate
Contact the Ohio Department of Insurance Consumer Services at 1-800-686-1526 if:
- Aetna improperly denies external review eligibility
- Appeal deadlines aren't met
- You need help navigating the process
When to Renew Authorization
Renewal Timeline
- Authorization period: 12 months
- Renewal submission: 30-60 days before expiration
- Required updates: Current functional assessments, treatment response documentation
What Changes at Renewal?
Your specialist must document continued medical necessity through:
- Updated pulmonary function tests (FVC)
- Motor function assessments
- Quality of life measures
- Evidence of ongoing clinical benefit
CVS Specialty Pharmacy Enrollment
Why Was My Prescription Transferred?
CVS Specialty is the exclusive distributor for Lumizyme. Regular retail pharmacies cannot dispense this medication due to specialized handling and administration requirements.
Enrollment Process
- Contact CVS Specialty: 1-800-237-2767 (24/7 pharmacist support)
- Complete enrollment: CVS Lysosomal Storage Enrollment Form
- Coordinate infusion: Home infusion via Coram (1-866-899-1661) or clinic-based administration
Required Information
- Patient demographics and insurance details
- Complete dosing specifications
- Infusion site preference
- Prescriber contact information
Troubleshooting Common Issues
Portal Problems
- Aetna member portal down: Call 1-866-752-7021 for status updates
- Missing forms: Download current versions from Aetna's precertification page
Communication Issues
- Delayed responses: Follow up within 5 business days of submission
- Missing documentation: Work with your clinic to ensure complete submission
Insurance Changes
- Plan switches: New prior authorization required with different insurer
- Address changes: Update both Aetna and CVS Specialty records
Frequently Asked Questions
How long does Aetna prior authorization take in Ohio? Standard prior authorization decisions take 14 days from complete submission. Expedited reviews with physician urgency certification are decided within 72 hours.
What if Lumizyme is non-formulary on my plan? Request a formulary exception by demonstrating medical necessity and documenting why formulary alternatives like Nexviazyme are inappropriate for your condition.
Can I request an expedited appeal in Ohio? Yes, if delaying treatment would seriously harm your health. Provide specialist documentation of urgent medical need for 72-hour decision timelines.
Does step therapy apply if I've been stable on Lumizyme? No, step therapy requirements don't apply to patients currently stable on Lumizyme therapy. Document your treatment history and clinical stability.
What happens if external review upholds the denial? You retain rights to file regulatory complaints with the Ohio Department of Insurance or pursue other legal remedies, though external review is usually the final administrative step.
How do I prove medical necessity for Lumizyme? Include confirmed Pompe disease diagnosis (enzyme assay or genetic testing), specialist prescription, functional assessments showing disease progression, and documentation of treatment response or failure with alternatives.
About Counterforce Health
Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters, plan policies, and clinical notes to identify denial reasons and draft point-by-point rebuttals aligned to each payer's specific requirements.
From our advocates: "We've seen Lumizyme approvals improve significantly when the prior authorization includes both enzyme testing results and functional assessments like 6-minute walk tests. Aetna particularly values documentation showing disease progression despite current treatment, which helps establish medical necessity even when step therapy requirements apply." (This represents a composite of best practices, not individual patient outcomes.)
For complex appeals involving rare disease treatments like Lumizyme, Counterforce Health provides the specialized expertise needed to navigate payer-specific workflows and procedural requirements, helping ensure your appeal includes the right clinical evidence and meets all documentation standards.
Sources & Further Reading
- Aetna Lumizyme Precertification Form (PDF)
- CVS Specialty Lysosomal Storage Enrollment Form
- Ohio Department of Insurance External Review Process
- Aetna Clinical Policy Bulletin: Enzyme Replacement Therapies
- Aetna Precertification Lists
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances, plan details, and medical necessity determinations. Always consult with your healthcare provider and insurance plan for specific guidance regarding your situation. For assistance with Ohio insurance appeals, contact the Ohio Department of Insurance Consumer Services at 1-800-686-1526.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.